Identification of the Human Mnk2 Gene (MKNK2) Through Protein Interaction with Estrogen Receptor Beta
Affiliations
We have identified and characterized the human Mnk2 gene (HGMW-approved gene symbol MKNK2) through a yeast two-hybrid screen in which the Mnk2 protein interacted with the ligand-binding domain of estrogen receptor beta (ERbeta). Human Mnk2 is homologous to murine Mnk2 ( approximately 94% identical) and human Mnk1 (71% identical), both of which encode MAP kinase interacting kinases that are phosphorylated and activated by ERK1 and 2. This report presents a thorough genomic sequence analysis revealing that the human Mnk2 gene has two C-terminal splice variants, designated here as Mnk2a and Mnk2b. These two isoforms are identical over the first 385 amino acids of the coding sequence and differ only in the final exon which encodes an additional 80 residues for Mnk2a and 29 residues for Mnk2b. A more detailed biological analysis in yeast showed that the Mnk2 interaction was selective for ERbeta as opposed to ERalpha and that the interaction was specific to Mnk2b as opposed to Mnk2a or Mnk1. This pattern was reproduced in a mammalian two-hybrid system using a completely different set of fusion partners; and in both yeast and mammalian systems, the addition of estradiol decreased the interaction. While it remains unknown whether ERbeta is a substrate of Mnk2, the interaction of these two proteins is reminiscent of ERalpha and ribosomal S6 kinase (p90-RSK), another MAP kinase-regulated kinase homologous to Mnk2 that is known to phosphorylate ERalpha.
Medicinal chemistry approaches to target the MNK-eIF4E axis in cancer.
Fernandez A, Monsen P, Platanias L, Schiltz G RSC Med Chem. 2023; 14(6):1060-1087.
PMID: 37360400 PMC: 10285747. DOI: 10.1039/d3md00121k.
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.
Bou-Petit E, Hummer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P J Med Chem. 2022; 65(8):6070-6087.
PMID: 35417652 PMC: 9059116. DOI: 10.1021/acs.jmedchem.1c01941.
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor.
Mal R, Magner A, David J, Datta J, Vallabhaneni M, Kassem M Front Oncol. 2020; 10:587386.
PMID: 33194742 PMC: 7645238. DOI: 10.3389/fonc.2020.587386.
The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.
Prabhu S, Moussa O, Miller Jr W, del Rincon S Int J Mol Sci. 2020; 21(11).
PMID: 32517051 PMC: 7312468. DOI: 10.3390/ijms21114055.
Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer.
Pinto-Diez C, Ferreras-Martin R, Carrion-Marchante R, Gonzalez V, Martin M Int J Mol Sci. 2020; 21(8).
PMID: 32340135 PMC: 7215568. DOI: 10.3390/ijms21082967.